Vor Biopharma Inc. (NYSE:VOR) Receives $10.92 Consensus Target Price from Analysts
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have updated their coverage on […]
More Stories
Tractor Supply (NASDAQ:TSCO) Upgraded by UBS Group to Strong-Buy
UBS Group upgraded shares of Tractor Supply (NASDAQ:TSCO – Free Report) from a hold rating to a strong-buy rating in...
Hub Group, Inc. (NASDAQ:HUBG) Receives Average Rating of “Hold” from Analysts
Shares of Hub Group, Inc. (NASDAQ:HUBG – Get Free Report) have received a consensus recommendation of “Hold” from the twelve...
Scorpio Tankers Inc. (NYSE:STNG) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Scorpio Tankers Inc. (NYSE:STNG – Get Free Report) have received an average rating of “Moderate Buy” from the...
TE Connectivity Ltd. (NYSE:TEL) Given Consensus Recommendation of “Hold” by Analysts
TE Connectivity Ltd. (NYSE:TEL – Get Free Report) has earned an average rating of “Hold” from the thirteen ratings firms...
Palomar Holdings, Inc. (NASDAQ:PLMR) Given Average Rating of “Moderate Buy” by Analysts
Shares of Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) have been given an average rating of “Moderate Buy” by...
Norfolk Southern Co. (NYSE:NSC) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Norfolk Southern Co. (NYSE:NSC – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the...